Cargando…
Can long-term thiamine treatment improve the clinical outcomes of myotonic dystrophy type 1?
Myotonic dystrophy type 1, also known as Steinert's disease, is an autosomal dominant disorder with multisystemic clinical features affecting the skeletal and cardiac muscles, the eyes, and the endocrine system. Thiamine (vitamin B1) is a cofactor of fundamental enzymes involved in the energeti...
Autores principales: | Costantini, Antonio, Trevi, Erika, Pala, Maria Immacolata, Fancellu, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090854/ https://www.ncbi.nlm.nih.gov/pubmed/27857755 http://dx.doi.org/10.4103/1673-5374.191225 |
Ejemplares similares
-
Oral High-Dose Thiamine Improves the Symptoms of Chronic Cluster Headache
por: Antonio, Costantini, et al.
Publicado: (2018) -
An open-label pilot study with high-dose thiamine in Parkinson's disease
por: Costantini, Antonio, et al.
Publicado: (2016) -
Myotonic dystrophy
por: Patterson, VH
Publicado: (1990) -
Validation of Motor Outcome Measures in Myotonic Dystrophy Type 2
por: Montagnese, Federica, et al.
Publicado: (2020) -
Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia
por: Finsterer, Josef, et al.
Publicado: (2017)